Opening Up the World of Drug Discovery: Scientist's Kevin Lustig

Listen to an interview with Kevin Lustig, PhD on the Mendelspod podcast...
Sean Preci
Published on
April 29, 2012

Listen to an interview with Kevin Lustig, PhD on the Mendelspod podcast.

Abstract molecular cluster with three connected blue-green spheres on a white background.

Take the Next Step

1
2
3

Explore Suppliers

Browse trusted partners with relevant expertise

Review Capabilities

Compare services, experience, and past work

Start Your Project

Connect and begin collaborating

Browse Suppliers
​
Post a Project
​
How It Works
​
Written by
Sean Preci
Share this post
TOPICS
​
Pharmacology

Subscribe to our newsletter

Subscribe to receive the latest news and innovations straight to your inbox.

Subscribe to our newsletter

Subscribe to receive the latest news and innovations straight to your inbox.

Read Further

​
Blog

The Evolving Landscape of Drug Discovery for Metabolic Diseases

Read blog
​
Blog

Regulatory Evolution in Substantial Evidence: The FDA’s One-Trial Pathway and the Strategic Implications for Biopharmaceutical Development

Read blog
​
Blog

June 2026 Medical/Commercial Pulse Check

Read blog
​
Blog

Accelerating the Design–Build–Test–Learn Cycle for AI-Driven Antibody Discovery

Read blog
​
Blog

Screening the Unscreenable: How Physics-Grounded AI Is Expanding the Reach of Drug Discovery

Read blog
​
Blog

Reducing risk in CRO studies: Choosing the right cell models for outsourced research

Read blog
​
Blog

Cutting Months Off AAV Programs: The Synthetic DNA Shift

Read blog
​
Blog

Speed Matters: Why RWE Acceleration Starts Upstream with Reusable Data

Read blog
​
Blog

Industry Insights: Behind the Scenes of BPS Bioscience Custom R&D

Read blog
​
Blog

Making Sustainability More "Sustainable": Driving Transformation at Scale within Biopharma

Read blog
​
Blog

Comprehensive Plasma cell-free RNA Profiling for Superior Cancer Detection

Read blog
​
Blog

Advanced Screening Strategies for Molecular Glue Discovery

Read blog
​
Blog

Why Large CROs and CDMOs Should Embrace Research Orchestration Platforms - Even with Existing Pharma Clients

Read blog
​
Blog

AI in HEOR: Three Ways Artificial Intelligence Is Accelerating Evidence Generation

Read blog
​
Blog

Supplier Spotlight: RadMD Imaging

Read blog
​
Blog

AI Is Expanding What's Possible in Drug Discovery. Operational Friction Still Determines How Fast It Happens.

Read blog
​
Blog

The Science of the "Gut Feeling": Why Techs are a Lab's Best Diagnostic Tool

Read blog
​
Blog

Supplier Spotlight: MedChemExpress

Read blog
​
Blog

HealthEconomics.com 2026 Pulse Check – March

Read blog
​
Blog

Cell Line-Derived Xenografts: A Reliable Platform for Preclinical Cancer Drug Testing

Read blog
​
Blog

2026 PharmDev Roadmap: The Regulatory Shift

Read blog
​
Blog

Five Reasons Leading CNS Programs Rely on BrainXell for Custom iPSC Models

Read blog
​
Blog

From the Colony to the Roadmap: The FDA's New Stance on NAMs and Why it Matters

Read blog
​
Blog

2026 PharmDev Roadmap: The Strategic Partner

Read blog
​
Blog

2026 PharmDev Roadmap: The Predictive Model

Read blog
​
Blog

2026 PharmDev Roadmap: The Complexity Spike

Read blog
​
Blog

Explore FUJIFILM's Cyclic Peptide Discovery Service

Read blog
​
Blog

2026 PharmDev Roadmap: The Resilience Pivot

Read blog
​
Blog

The Biosecure Act: Navigating Changes in the Biopharma Supply Chain

Read blog
​
Blog

Evolving Frontiers in Immunohistochemistry: Applications and Transformations in Modern Biotechnology

Read blog

Read Further

​
blog

How Preclinical Quality Certifications Help Foster Biopharma-CRO Partnerships [Webinar]

Read blog
​
blog

Life Science Startup Nightmares

Read blog
​
blog

Looking for Ways to Streamline Your Cell-Based Assays Using Fresh or Frozen Leukopaks?

Read blog
​
blog

Helping the Life Science Industry Accelerate R&D

Read blog
​
See it in Action

The Digital Backbone for Modern Life Sciences

Discover how one intelligent platform helps teams connect providers, workflows, approvals, compliance, data, and spend—so complex projects move faster with greater visibility and control.

​
Request a Personalized Demo